Romano Kelly A 4
4 · Athira Pharma, Inc. · Filed Jun 25, 2024
Insider Transaction Report
Form 4
Romano Kelly A
Director
Transactions
- Purchase
Common Stock
2024-06-21$2.26/sh+15,000$33,872→ 53,315 total - Purchase
Common Stock
2024-06-24$2.42/sh+27,400$66,179→ 80,715 total
Footnotes (2)
- [F1]The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.20 to $2.32, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.
- [F2]The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.39 to $2.43, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.